Literature DB >> 1648675

Evidence that histamine H3 receptors are involved in the control of gastric acid secretion in the conscious cat.

G Coruzzi1, G Bertaccini, J C Schwartz.   

Abstract

In an attempt to assess the role of histamine H3 receptors in the control of gastric acid secretion, the effects of the selective histamine H3 receptor agonist, (R) alpha-methylhistamine and antagonist, thioperamide were evaluated in the conscious gastric fistula cat under basal conditions and against different stimuli. (R) alpha-methylhistamine (0.05-0.2 mumol/kg/h) was ineffective against spontaneous and dimaprit-induced acid secretion; it also did not reduce significantly pentagastrin-induced acid output, but caused a dose-dependent (0.05-0.1 mumol/kg/h) and significant inhibition of the acid response to 2-deoxy-D-glucose. Thioperamide (0.02-0.04 mumol/kg/h) did not modify spontaneous acid secretion, whereas it evoked a significant enhancement of the acid response to submaximal doses (50 mg/kg i.v.) of 2-deoxy-D-glucose. Thioperamide completely reversed the inhibitory effect of (R) alpha-methylhistamine against 2-deoxy-D-glucose-induced secretion, while leaving unaffected the inhibition induced by somatostatin. These data suggest that histamine H3 receptors may be involved in the control of acid secretion stimulated by indirectly acting secretagogues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648675     DOI: 10.1007/bf00168615

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Inhibition of guinea pig ileum contractions mediated by a class of histamine receptor resembling the H3 subtype.

Authors:  J P Trzeciakowski
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

2.  Highly potent and selective ligands for histamine H3-receptors.

Authors:  J M Arrang; M Garbarg; J C Lancelot; J M Lecomte; H Pollard; M Robba; W Schunack; J C Schwartz
Journal:  Nature       Date:  1987 May 14-20       Impact factor: 49.962

3.  A novel class (H3) of histamine receptors on perivascular nerve terminals.

Authors:  S Ishikawa; N Sperelakis
Journal:  Nature       Date:  1987 May 14-20       Impact factor: 49.962

4.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

5.  Vagal gastric secretory stimulation by 2-deoxy-D-glucose.

Authors:  B I Hirschowitz; G Sachs
Journal:  Am J Physiol       Date:  1965-09

6.  Histamine release in the isolated vascularly perfused stomach of the rat: regulation by autoreceptors.

Authors:  A K Sandvik; M J Lewin; H L Waldum
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

7.  Pharmacological control of the human gastric histamine H2 receptor by famotidine: comparison with H1, H2 and H3 receptor agonists and antagonists.

Authors:  C Gespach; D Fagot; S Emami
Journal:  Eur J Clin Invest       Date:  1989-02       Impact factor: 4.686

8.  Histamine H3-receptors inhibit cholinergic neurotransmission in guinea-pig airways.

Authors:  M Ichinose; C D Stretton; J C Schwartz; P J Barnes
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

9.  The location of the chemoreceptor controlling gastric acid secretion during hypoglycaemia.

Authors:  D G Colin-Jones; R L Himsworth
Journal:  J Physiol       Date:  1970-02       Impact factor: 5.182

10.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

  10 in total
  14 in total

1.  Gastric antisecretory effects of compound BP 2-94: a histamine H3-receptor agonist prodrug.

Authors:  G Soldani; S Bertini; A Rouleau; J C Schwartz; G Coruzzi
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 2.  An update on histamine H3 receptors and gastrointestinal functions.

Authors:  G Bertaccini; G Coruzzi
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

3.  Pharmacological profile of new thioperamide derivatives at histamine peripheral H1-, H2-, H3-receptors in guinea-pig.

Authors:  E Barocelli; V Ballabeni; A Caretta; F Bordi; C Silva; G Morini; M Impicciatore
Journal:  Agents Actions       Date:  1993-03

4.  The histamine H3 receptor agonist N alpha-methylhistamine produced by Helicobacter pylori does not alter somatostatin release from cultured rabbit fundic D-cells.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

5.  Histamine 3 receptor activation mediates inhibition of acid secretion during Helicobacter-induced gastritis.

Authors:  Yana Zavros; Nisreen Mesiwala; Meghna Waghray; Andrea Todisco; Arthur Shulkes; Juanita L Merchant
Journal:  World J Gastrointest Pathophysiol       Date:  2010-12-15

6.  Effect of N alpha-methyl-histamine on acid secretion in isolated cultured rabbit parietal cells: implications for Helicobacter pylori associated gastritis and gastric physiology.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

7.  Regulation of gastric acid secretion by histamine H3 receptors in the dog: an investigation into the site of action.

Authors:  G Soldani; L Intorre; S Bertini; E Luchetti; G Coruzzi; G Bertaccini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

8.  Histamine H3 receptor-mediated inhibition of gastric acid secretion in conscious dogs.

Authors:  G Soldani; G Mengozzi; L Intorre; G De Giorgi; G Coruzzi; G Bertaccini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

9.  R-alpha-methylhistamine-induced inhibition of gastric acid secretion in pylorus-ligated rats via central histamine H3 receptors.

Authors:  E Barocelli; V Ballabeni; M Chiavarini; M Impicciatore
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

Review 10.  New molecular targets for treatment of peptic ulcer disease.

Authors:  Frank Lehmann; Pius Hildebrand; Christoph Beglinger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.